A phase 1 study of combined guadecitabine and cisplatin in platinum refractory germ cell cancer

PURPOSE: Germ cell tumors (GCTs) are cured with therapy based on cisplatin, although a clinically significant number of patients are refractory and die of progressive disease. Based on preclinical studies indicating that refractory testicular GCTs are hypersensitive to hypomethylating agents (HMAs),...

Full description

Saved in:
Bibliographic Details
Published in:Cancer Med
Main Authors: Albany, Costantine, Fazal, Zeeshan, Singh, Ratnakar, Bikorimana, Emmanuel, Adra, Nabil, Hanna, Nasser H., Einhorn, Lawrence H., Perkins, Susan M., Sandusky, George E., Christensen, Brock C., Keer, Harold, Fang, Fang, Nephew, Kenneth P., Spinella, Michael J.
Format: Artigo
Language:Inglês
Published: John Wiley and Sons Inc. 2020
Subjects:
Clinical Cancer Research
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC7826483/
https://ncbi.nlm.nih.gov/pubmed/33135391
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.3583
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items